1. B Zycker et al. (2008) The truth about drug innovation: thirty-five summary case histories on private sector contributors to pharmaceutical science. Center for Medical progress at the Manhattan University. Medical Progress Report, No 6 June 2008 (http://www.manhattan-institute.org/html/mpr_06.htm)
2. In-Pharma Technologist.com: “M&A fever sweeps drug industry in wake of Pfizer-Wyeth deal” (http://www.in-pharmatechnologist.com/Industry-Drivers/M-A-fever-sweeps-drug-industry-in-wake-of-Pfizer-Wyeth-deal)
3. Philadelphia Inquirer: “Experts: Wyeth pipeline not that attractive” (http://www.philly.com/philly/business/38520187.html)
4. R&D Directions (http://www.pharmalive.com/magazines/randd/ http://www.pharmalive.com/magazines/randd/view.cfm?articleid=6999&search=1 http://www.astrazeneca-us.com/careers/?itemId=4555175)
5. These statistics come from John Patterson's “Viewpoint” in Pharmaceutical Technology Magazine, “Can Big Pharma Produce the Next Generation of Medicines?”, August 2, 2008